• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对纳入RegiSCAR研究的一组史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症患者进行SCORTEN评估。

Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study.

作者信息

Sekula Peggy, Liss Yvonne, Davidovici Batya, Dunant Ariane, Roujeau Jean-Claude, Kardaun Sylvia, Naldi Luigi, Schumacher Martin, Mockenhaupt Maja

机构信息

Department of Medical Biometry and Statistics, Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Germany.

出版信息

J Burn Care Res. 2011 Mar-Apr;32(2):237-45. doi: 10.1097/BCR.0b013e31820aafbc.

DOI:10.1097/BCR.0b013e31820aafbc
PMID:21228709
Abstract

The purpose of this study was to evaluate the severity-of-illness score called SCORTEN with respect to its predictive ability and by using data obtained in the RegiSCAR study, the most comprehensive European registry of patients with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). For advanced comparisons, an auxiliary score (AS) was defined using data obtained in a previous study. Three hundred sixty-nine patients with SJS/TEN were included in RegiSCAR between 2003 and 2005. The data needed for calculation of SCORTEN were available for 45% of patients. The score revealed a moderate predictive ability with a slight underestimation of the total number of in-hospital deaths by 11%, an area under the receiver operating characteristic curve of 0.75, and a Brier score of 0.14. Problems could be seen by analyzing subgroups such as patients with TEN. The AS was better calibrated but discriminated worse (area under the receiver operating characteristic curve: 0.72; Brier score: 0.14). With the help of a refined score derived from SCORTEN and AS, potential for a possible improvement could be demonstrated. The authors were able to show that the predictive ability of SCORTEN is acceptable. Although improvement might be possible, SCORTEN remains the tool of choice, whereas AS might be an alternative in retrospective settings with missing laboratory data.

摘要

本研究的目的是评估名为SCORTEN的疾病严重程度评分的预测能力,并利用在RegiSCAR研究中获得的数据进行评估。RegiSCAR研究是欧洲关于史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)患者最全面的登记研究。为了进行进一步比较,使用先前研究中获得的数据定义了一个辅助评分(AS)。2003年至2005年期间,RegiSCAR纳入了369例SJS/TEN患者。45%的患者可获得计算SCORTEN所需的数据。该评分显示出中等的预测能力,住院死亡总数略有低估,低估了11%,受试者工作特征曲线下面积为0.75,Brier评分为0.14。通过分析TEN患者等亚组可以发现问题。AS校准得更好,但区分能力较差(受试者工作特征曲线下面积:0.72;Brier评分:0.14)。借助从SCORTEN和AS得出的改进评分,可以证明有可能进行改进。作者能够证明SCORTEN的预测能力是可以接受的。虽然可能有改进的空间,但SCORTEN仍然是首选工具,而AS可能是在实验室数据缺失的回顾性研究中的一种替代方法。

相似文献

1
Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study.对纳入RegiSCAR研究的一组史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症患者进行SCORTEN评估。
J Burn Care Res. 2011 Mar-Apr;32(2):237-45. doi: 10.1097/BCR.0b013e31820aafbc.
2
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.Stevens-Johnson 综合征/中毒性表皮坏死松解症患者住院死亡率风险预测模型的建立与验证-ABCD-10
JAMA Dermatol. 2019 Apr 1;155(4):448-454. doi: 10.1001/jamadermatol.2018.5605.
3
Comparing the Accuracy of ABCD-10 and SCORTEN in Predicting the In-Hospital Mortality of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multi-Institutional Study from Central China.比较 ABCD-10 和 SCORTEN 在预测 Stevens-Johnson 综合征/中毒性表皮坏死松解症住院死亡率中的准确性:来自中国中部的多机构研究。
Dermatology. 2022;238(4):736-744. doi: 10.1159/000520494. Epub 2021 Dec 7.
4
A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的临床治疗分析,重点关注中毒性表皮坏死松解症评分(SCORe of Toxic Epidermal Necrolysis)的预测价值和准确性。
Int J Dermatol. 2015 Jan;54(1):e18-26. doi: 10.1111/ijd.12466.
5
Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的眼部表现及其与 SCORTEN 的关系。
Am J Ophthalmol. 2010 Oct;150(4):505-510.e1. doi: 10.1016/j.ajo.2010.04.026. Epub 2010 Jul 8.
6
Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis.评估和比较 ABCD-10 和 SCORTEN 在预测表皮松解坏死症中的性能。
JAMA Dermatol. 2020 Dec 1;156(12):1294-1299. doi: 10.1001/jamadermatol.2020.3654.
7
Cohort study of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in China: evaluation of risk models and new predictor of pulmonary consolidation on computed tomography.中国 Stevens-Johnson 综合征和中毒性表皮坏死松解症患者的队列研究:风险模型评估和 CT 上肺实变的新预测因子。
Front Med. 2021 Aug;15(4):585-593. doi: 10.1007/s11684-020-0817-2. Epub 2021 Mar 1.
8
Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study.中毒性表皮坏死松解症患者的流行病学与费用:一项27年的回顾性研究。
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2444-50. doi: 10.1111/jdv.13352. Epub 2015 Sep 28.
9
Pediatric toxic epidermal necrolysis: using SCORTEN and predictive models to predict morbidity when a focus on mortality is not enough.小儿中毒性表皮坏死松解症:当仅关注死亡率不足够时,使用SCORTEN及预测模型来预测发病率
J Burn Care Res. 2015 Jan-Feb;36(1):167-77. doi: 10.1097/BCR.0000000000000204.
10
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis: The Role of Novel Inflammatory Markers and Proposed Revision of SCORTEN (Re-SCORTEN).表皮松解型坏死性松解症患者死亡率预测的改善:新型炎症标志物的作用和 SCORTEN(再-SCORTEN)的修订建议。
JAMA Dermatol. 2022 Feb 1;158(2):160-166. doi: 10.1001/jamadermatol.2021.5119.

引用本文的文献

1
Cyclosporin for the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): a systematic review of observational studies and clinical trials focusing on single therapy, combination therapy, and comparative assessments.环孢素治疗史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN):一项关于观察性研究和临床试验的系统评价,重点关注单一疗法、联合疗法及对比评估。
Inflammopharmacology. 2025 Feb;33(2):485-503. doi: 10.1007/s10787-024-01590-0. Epub 2024 Oct 29.
2
Clinico- Therapeutic Study of Stevens Johnson Syndrome-Toxic Epidermal Necrolysis and Prognostic Significance of SCORTEN in Indian Patients.史蒂文斯-约翰逊综合征-中毒性表皮坏死松解症的临床治疗研究及SCORTEN对印度患者的预后意义
Indian J Dermatol. 2024 Jan-Feb;69(1):24-31. doi: 10.4103/ijd.ijd_612_23. Epub 2024 Feb 27.
3
Multidisciplinary Treatment in Toxic Epidermal Necrolysis.中毒性表皮坏死松解症的多学科治疗。
Int J Environ Res Public Health. 2023 Jan 26;20(3):2217. doi: 10.3390/ijerph20032217.
4
IL-15/IL-15Rα in SJS/TEN: Relevant Expression of and in Affected Skin.中毒性表皮坏死松解症/重症多形红斑中的白细胞介素-15/白细胞介素-15受体α:在受累皮肤中的相关表达情况
Biomedicines. 2022 Aug 2;10(8):1868. doi: 10.3390/biomedicines10081868.
5
Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的评分评估
Front Med (Lausanne). 2022 Jun 16;9:883121. doi: 10.3389/fmed.2022.883121. eCollection 2022.
6
Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China.静脉注射免疫球蛋白联合皮质类固醇治疗史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症:中国一项倾向匹配的回顾性研究
Front Pharmacol. 2022 Jan 18;12:750173. doi: 10.3389/fphar.2021.750173. eCollection 2021.
7
Vulvovaginal and ocular involvement and treatment in female patients with Stevens-Johnson syndrome and toxic epidermal necrolysis: A review.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症女性患者的外阴阴道及眼部受累情况与治疗:一项综述
Int J Womens Dermatol. 2021 Sep 2;7(5Part A):520-528. doi: 10.1016/j.ijwd.2021.08.012. eCollection 2021 Dec.
8
Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions.与严重皮肤不良反应相关的药物性肝损伤诊断与管理差距的批判性综述
J Clin Med. 2021 Nov 15;10(22):5317. doi: 10.3390/jcm10225317.
9
Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).严重皮肤不良反应表皮坏死松解症(EN)的临床和发病方面。
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1957-1971. doi: 10.1111/jdv.16339. Epub 2020 May 15.
10
Genetic testing for prevention of severe drug-induced skin rash.用于预防严重药物性皮疹的基因检测。
Cochrane Database Syst Rev. 2019 Jul 17;7(7):CD010891. doi: 10.1002/14651858.CD010891.pub2.